Human medicines European public assessment report (EPAR): Nexavar, sorafenib, Carcinoma, Hepatocellular,Carcinoma, Renal Cell, Date of authorisation: 19/07/2006, Revision: 28, Status: Authorised

2019 ◽  
Author(s):  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Renal Cell ◽  
Assessment Report ◽  
European Public ◽  
European Public Assessment Report ◽  
Carcinoma Renal Cell ◽  
Carcinoma Hepatocellular
Sign in / Sign up

Export Citation Format

Share Document